UK's Top Lung Cancer Experts in Modern Oncology

Lung cancer remains one of the most complex and challenging diagnoses in modern medicine, accounting for more cases of cancer-related mortality in the United Kingdom than any other cancer type. Advances in surgical technique, radiotherapy precision, and molecular oncology have transformed what is possible for patients, turning conditions that once carried a grim prognosis into manageable and, in many cases, curable diseases. The surgeons and oncologists practising at the forefront of this field are not merely clinicians; they are researchers, innovators, and advocates reshaping the landscape of thoracic care.

Identifying the right specialist is one of the most consequential decisions a lung cancer patient or their family can make. Across the UK, a remarkable group of consultants is advancing treatment through minimally invasive surgery, evidence-based protocols, and pioneering therapies that were unimaginable just a decade ago. This article profiles ten of the country's most distinguished lung cancer experts, each contributing to the field in their own exceptional way, and each worth knowing about when navigating the path toward the best possible care.

Dr. James Wilson: London's Leading Lung Cancer Oncologist

A Specialist Built on World-Class Training

Dr. James Wilson is a Consultant Clinical Oncologist based in central London, widely regarded as one of the most accomplished lung cancer specialists practising in the UK today. His academic formation reads as a compendium of the world's finest medical institutions: the University of Oxford, the Royal Marsden Hospital, and Massachusetts General Hospital in Boston. That training equipped him with a rare dual qualification in both medical oncology and radiation oncology, allowing him to approach each patient's case from a uniquely comprehensive perspective. Where most specialists are confined to either systemic treatment or radiotherapy, Dr. Wilson navigates both with equal fluency, building treatment plans that integrate the most effective modalities from the outset.

Precision Radiotherapy and the Power of Personalised Care

Dr. Wilson's clinical practice sits at the intersection of radiotherapy innovation and precision medicine. He is highly experienced in Stereotactic Ablative Radiotherapy (SABR), a technique that delivers concentrated, high-dose radiation to early-stage lung tumours with extraordinary accuracy, achieving tumour control rates exceeding 90% without the need for surgery. For patients with advanced disease, he employs Proton Beam Therapy and MR Linac technology to target tumours while sparing surrounding healthy tissue. Underpinning all of this is a commitment to molecular profiling: each patient's tumour is genetically analysed to identify the most effective targeted therapy, ensuring that no treatment decision is made without a precise biological rationale. Patients see Dr. Wilson for every appointment, from the first consultation through to follow-up, delivering a continuity of care that is increasingly rare in modern oncology.

Rapid Access and a Patient-Centred Philosophy

One of the most practically significant aspects of Dr. Wilson's practice is his dedication to speed and accessibility. He offers consultations within 48 hours and, where clinically appropriate, begins treatment within a week of diagnosis. For patients facing time-sensitive decisions, that responsiveness can be the difference between accessing a curative intervention and missing the window for one. He also works collaboratively alongside NHS teams, ensuring that private treatment integrates seamlessly with existing care rather than replacing or disrupting it. Dr. Wilson is registered with the General Medical Council, is a Fellow of the Royal College of Physicians and the Royal College of Radiologists, and holds membership of the Royal Society of Medicine. For patients seeking an oncologist who combines world-class technical expertise with a genuinely personalised approach, Dr. James Wilson represents the very best that modern lung cancer care has to offer.

Joel Dunning: The Evidence-Based Pioneer of the North East

A Career Defined by Rigorous Research

Professor Joel Dunning is a Consultant Cardiothoracic Surgeon at James Cook University Hospital in Middlesbrough, operating under the umbrella of South Tees Hospitals NHS Foundation Trust. His career has been built as much in the research laboratory and academic publishing house as in the operating theatre, with over 150 peer-reviewed publications to his name and a citation record that places him among the most referenced thoracic surgeons in the United Kingdom. His academic contributions span evidence-based surgical methodology, outcomes research, and the systematic evaluation of minimally invasive techniques, making him not only a gifted surgeon but a trusted voice in shaping national clinical standards.

Mastery of Minimally Invasive Thoracic Surgery

Professor Dunning has been instrumental in advancing Video-Assisted Thoracoscopic Surgery (VATS) as a primary approach to lung cancer resection in the UK. His involvement in landmark clinical trials, including research comparing VATS lobectomy with open surgery for early-stage lung cancer, has provided the evidence base that now underpins national guidelines. His technical skill in VATS lobectomy and thymectomy is well-documented, and patients at James Cook University Hospital benefit from a surgeon who has both refined and validated the very procedures he performs. His commitment to training the next generation of thoracic surgeons is equally notable, and his educational content on platforms such as CTSNet has been accessed by thousands of surgeons across the world.

An International Presence Rooted in Local Excellence

Beyond the UK, Professor Dunning's reputation extends across continents. He has lectured and taught at major international cardiothoracic conferences, participated in collaborative research with institutions in Europe and the United States, and contributed to the global conversation about best practice in chest surgery. His international profile is not merely a badge of prestige; it reflects a surgeon who is constantly informed by the best evidence from across the world and brings that knowledge directly to his patients in Middlesbrough. For those in the North East of England seeking thoracic surgery of the highest calibre, Professor Dunning offers a combination of academic rigour, technical mastery, and genuine dedication to patient outcomes that is difficult to match.

Elizabeth Belcher: Oxford's Dedicated Thoracic Surgeon

A Specialist at One of the UK's Finest Hospitals

Ms Elizabeth Belcher is a Consultant Thoracic Surgeon at Oxford University Hospitals NHS Foundation Trust, one of the most prestigious academic medical centres in the country. Holding qualifications as both an MRCP and an FRCS (CTh) as well as a PhD, Ms Belcher represents the rare combination of physician and surgeon, a clinician whose deep understanding of respiratory medicine informs every technical decision she makes in the operating theatre. Her base at the John Radcliffe Hospital places her within a multidisciplinary environment that draws on some of the country's finest pathologists, oncologists, and respiratory physicians.

Minimally Invasive Surgery and Research Contributions

Ms Belcher specialises in minimally invasive thoracoscopic surgery for lung cancer, and her published academic work includes influential research into optimal lung cancer resection rates in the UK. Her 2021 study in BMJ Open Respiratory Research examined whether high-performing centres were truly achieving the best possible surgical resection rates for early-stage lung cancer, contributing meaningfully to national debates about access and quality of care. She is also involved in CT follow-up programmes for post-surgical lung cancer patients, helping to identify those with potentially curable recurrences at the earliest stage.

Championing Access and Surgical Excellence

Ms Belcher is known not only for her technical ability but for her advocacy on behalf of patients who may not receive timely access to surgery. Her research consistently highlights the gap between current practice and what could be achieved, making her a valuable voice in healthcare policy as well as at the operating table. She is listed with the Society for Cardiothoracic Surgery in Great Britain and Ireland and continues to contribute to the academic and clinical mission of Oxford University Hospitals. Patients fortunate enough to be under her care receive treatment that is informed by cutting-edge research and delivered with genuine commitment.

Mike Shackcloth: Liverpool's Award-Winning Thoracic Innovator

A Nationally Recognised Leader in Thoracic Surgery

Mr Mike Shackcloth is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital, one of the busiest and most respected specialist cardiac and thoracic centres in the United Kingdom. His contributions to thoracic surgery over the course of his career have earned him widespread recognition, most notably the prestigious 2024 Golden Lungs Trainer Award, a national accolade recognising outstanding commitment to surgical education and the development of the next generation of thoracic surgeons. That recognition reflects a career not only defined by excellence in the operating theatre but by a sustained investment in sharing knowledge and standards across the profession.

Minimally Invasive Surgery and Pioneering Clinical Trials

Mr Shackcloth's specialist interests are centred on minimally invasive thoracic surgery, and he has played a significant role in the VIOLET trial, a landmark UK multi-centre randomised controlled trial comparing VATS surgery with open thoracotomy for lung cancer. His participation in that research helped produce findings of national and international importance, demonstrating the tangible clinical benefits of keyhole approaches for patients with early-stage lung cancer. In addition to VATS lobectomy, his expertise extends to metastasectomy, lung volume reduction surgery, and the surgical management of oesophageal malignancies, giving him a broad and accomplished thoracic surgical portfolio.

Innovation Beyond the Operating Theatre

Mr Shackcloth and his colleagues at Liverpool Heart and Chest Hospital have been at the forefront of adopting new surgical technologies, including the Echelon 3000 device, which he and Mr Julius Asante-Siaw were the first surgeons in the UK to use for thoracic procedures. That willingness to adopt and evaluate new technology speaks to a culture of innovation within his practice that directly benefits patients. With an extensive publication record spanning 150 research works and over 9,000 citations, his influence on the field extends far beyond Liverpool. Mr Shackcloth is a clinician whose combination of surgical expertise, research contribution, and educational dedication makes him a truly outstanding figure in UK thoracic oncology.

Francesco Di Chiara: Oxford's Uniportal VATS Pioneer

A Surgeon of International Credentials

Mr Francesco Di Chiara is a Consultant Thoracic Surgeon at Oxford University Hospitals, where he has made a distinctive mark by introducing uniportal VATS surgery (single-incision keyhole surgery) to the institution. He trained at the world-renowned Padua Medical School in Italy before undertaking extensive postgraduate surgical training across cardiac, thoracic, and lung transplantation disciplines in both Italy and the United Kingdom. His qualifications include a Master of Surgery with Honours in Thoracic Surgery and the prestigious European Fellowship of the Board of Thoracic Surgery (FEBTS), placing him among an elite cohort of European thoracic surgeons with formally validated excellence.

A Breadth of Expertise Across Complex Thoracic Conditions

Mr Di Chiara's clinical interests at Oxford encompass lung cancer, sarcoma, chest wall surgery, and thoracic outlet syndrome, reflecting a thoracic surgical practice of considerable breadth. His nine years of dedicated training in thoracic surgery have given him familiarity with the full spectrum of thoracic surgical interventions, and his introduction of single-incision keyhole surgery at Oxford University Hospitals has offered patients access to one of the most technically demanding and patient-friendly surgical approaches available in modern thoracic oncology.

Research, Training, and a European Perspective

Beyond his clinical practice, Mr Di Chiara is an active contributor to the European thoracic surgical community, having presented and published within the European Association for Cardio-Thoracic Surgery network. His combination of Italian surgical heritage and rigorous UK specialist training gives his practice a distinctly international dimension. Patients under his care at the John Radcliffe Hospital benefit from a surgeon who operates at the highest technical level and brings a global perspective to the treatment of thoracic malignancies.

Vladimir Anikin: Harefield's Master of Complex Thoracic Oncology

A Career Spanning Three Decades and Two Continents

Professor Vladimir Anikin is a Consultant Thoracic Surgeon at Harefield Hospital, part of the Royal Brompton and Harefield group, one of the most iconic cardiothoracic hospitals in the world. His career began with specialist thoracic surgical oncology training at the PA Hertzen Cancer Research Institute in Moscow in the early 1980s, giving him a depth of surgical experience and technical grounding that few contemporaries can match. That foundation was built upon through decades of practice at some of the finest thoracic surgical institutions in the United Kingdom, culminating in his current role at Harefield, where he sees both NHS and private patients.

Expertise in Locally Advanced and Reconstructive Surgery

Professor Anikin's areas of expertise are particularly notable for their complexity. He is recognised for his work in surgery for locally advanced tumours of the chest, reconstructive lung surgery, and cryosurgery, as well as the surgical treatment of lung cancer in all its forms. His command of both VATS and open surgical approaches to oesophageal and lung cancer, alongside his expertise in tracheal stenosis, makes him one of the most versatile thoracic oncological surgeons practising in the UK today. Patients with complicated presentations, those who have been told that surgery is not straightforward, frequently find in Professor Anikin a surgeon equipped to take on precisely those challenges.

Research, Publications, and a Legacy of Clinical Excellence

Professor Anikin's academic contributions have enriched the field across multiple decades. He has participated in significant UK multi-centre clinical trials, including research into minimally invasive versus open surgery for primary lung cancer, and his published expertise spans a broad range of thoracic conditions. His presence at Harefield Hospital, a centre synonymous with surgical innovation and excellence, provides the ideal setting for a clinician of his stature. For patients facing complex thoracic malignancies, the combination of Professor Anikin's extraordinary experience, technical range, and long-standing reputation at one of the UK's finest hospitals makes him an exceptional choice of surgeon.

Susannah Love: Liverpool's Rising Thoracic Surgical Star

A Consultant Earning Recognition at Every Stage

Miss Susannah Love is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital, a specialist who has earned recognition not only for her surgical skill but for the warmth and dedication with which she approaches patient care. Her distinction as an Employee of the Month winner at Liverpool Heart and Chest Hospital is a small but telling detail, reflecting the regard in which she is held by both colleagues and patients. She is listed with the Society for Cardiothoracic Surgery in Great Britain and Ireland and forms part of one of the most accomplished thoracic surgical teams in the North West of England.

A Broad Thoracic Surgical Practice

Miss Love's clinical practice encompasses the management of lung cancer and mesothelioma, oesophageal cancer, and a range of other complex thoracic conditions. Her involvement in the first laser-assisted lung cancer surgery performed at Liverpool Heart and Chest Hospital is a testament to her commitment to embracing innovation and expanding the technological capability of her department. Her academic contributions include research into pulmonary metastasectomy in metastatic breast cancer, a field where the evidence base remains an active subject of clinical debate and investigation.

Part of a World-Class Thoracic Surgical Team

Miss Love operates within a department that consistently performs at the highest level of national benchmarking, alongside colleagues including Mr Mike Shackcloth and Mr Julius Asante-Siaw. That environment of collaborative excellence shapes the standard of care available to every patient who comes through Liverpool Heart and Chest Hospital's thoracic surgery programme. For patients in the North West seeking a skilled, compassionate, and forward-thinking thoracic surgeon, Miss Susannah Love is a name very much worth knowing.

Tim Batchelor: Bristol's ERAS Champion and VATS Innovator

Training, Leadership, and an Evidence-Based Career

Mr Tim Batchelor is a Consultant Thoracic Surgeon in Bristol, where his career has been defined by a powerful combination of technical surgical skill and a rigorous commitment to evidence-based practice. He graduated from Edinburgh University Medical School in 1995 and completed his cardiothoracic surgical training across Scotland and Yorkshire, before establishing himself as one of the leading thoracic surgeons in the South West of England. His academic output and leadership roles have made him a nationally recognised figure in the field, and his contributions to the literature on VATS lobectomy and enhanced recovery after surgery are widely cited by researchers and clinicians across the UK and beyond.

The ERAS Society and National Guideline Development

Mr Batchelor serves as the lead for thoracic surgery within the ERAS (Enhanced Recovery After Surgery) Society and is the lead author of the international guidelines for enhanced recovery after lung cancer surgery. That role carries extraordinary significance: the ERAS guidelines are adopted by hospitals across the world, and Mr Batchelor's authorship of the thoracic surgery edition means that his clinical thinking directly shapes how patients recover from lung cancer surgery on a global scale. His involvement in the VIOLET randomised controlled trial further cements his credentials as a surgeon committed to generating and applying the highest quality clinical evidence.

A Surgeon Who Has Shaped National and International Practice

The breadth of Mr Batchelor's influence on thoracic surgery extends from the operating room in Bristol to international congresses and clinical guidelines consulted by surgeons from Edinburgh to Tokyo. His research on health-related quality of life following VATS surgery, published in peer-reviewed journals, has added important patient-centred data to the clinical case for minimally invasive approaches to lung cancer resection. His dual role as a practising surgeon and a driving force behind best-practice guideline development positions him as one of the most consequential thoracic surgeons in the country. Patients in Bristol and across the South West are fortunate to have a clinician of his standing at the forefront of their care.

Julius Asante-Siaw: Clinical Lead and Surgical Innovator in Liverpool

Leadership at the Liverpool Lung Cancer Unit

Mr Julius Asante-Siaw serves as Consultant Thoracic Surgeon and Clinical Lead for Thoracic Surgery at Liverpool Heart and Chest Hospital, and as the clinical lead of the Liverpool Lung Cancer Unit. That leadership position reflects the confidence his institution places in both his surgical ability and his capacity to drive forward the strategic direction of thoracic oncological care in one of England's major cities. His role spans not only the operating theatre but the broader governance and development of lung cancer services, making him a clinician whose impact extends across entire patient pathways rather than individual cases.

Embracing Surgical Innovation

Mr Asante-Siaw has been consistently at the vanguard of adopting new surgical technologies. Alongside Mr Mike Shackcloth, he was among the first surgeons in the UK to use the new Echelon 3000 stapling devices in thoracic surgery, and he was centrally involved in the first laser-assisted lung cancer surgery performed at Liverpool Heart and Chest Hospital, a landmark achievement for the institution and for thoracic oncology in the North West. His readiness to evaluate and adopt emerging technologies speaks to a clinical philosophy rooted in continuous improvement and a commitment to offering patients the most advanced options available.

A Trusted Figure in North West Thoracic Oncology

As Clinical Lead, Mr Asante-Siaw occupies a position of considerable influence within Liverpool's thoracic surgical community, coordinating the work of a multidisciplinary team that includes oncologists, pathologists, and specialist nurses. His reputation with colleagues and patients alike reflects a surgeon who combines technical excellence with effective leadership, making him a pivotal figure in the delivery of lung cancer surgery in the North West. Those seeking specialist thoracic care in the region will find in Mr Asante-Siaw a surgeon of both impressive skill and genuine institutional commitment.

Doug West: Bristol's Thoracic Surgeon and Quality Improvement Champion

A Surgeon with a Focus on Outcomes and Audit

Mr Doug West is a Consultant Thoracic Surgeon based in Bristol, where his practice is distinguished by a particularly strong emphasis on surgical audit, quality improvement, and the rigorous measurement of patient outcomes. His role as Thoracic Surgery Audit Lead for the Society for Cardiothoracic Surgery in Great Britain and Ireland reflects the trust his peers place in his analytical approach to clinical practice. Armed with training from the London School of Hygiene and Tropical Medicine, Mr West brings an unusually strong epidemiological and methodological foundation to his work, an asset of considerable value in a field where the evidence base is constantly evolving.

Research into Lung Cancer Surgery Outcomes

Mr West's research contributions are focused on understanding what drives the best outcomes for lung cancer patients undergoing surgery. His work includes investigation into blood-based tumour markers for early-stage lung cancer detection, outcomes research relating to minimally invasive versus open approaches, and studies examining factors that predict length of hospital stay following thoracic resection. That body of work feeds directly into the quality improvement agenda he champions at both the institutional and national levels, helping to ensure that the standard of lung cancer surgery in the UK continues to improve year on year.

A Clinician Committed to Raising the Bar

Mr West's dual identity as a practising thoracic surgeon and a data-driven quality improvement lead makes him a distinctive and valuable presence in UK lung cancer care. His involvement with multi-centre clinical trials and national audit processes means that his clinical insights are shaped by evidence gathered not just from his own patients but from centres across the country. Patients under his care in Bristol benefit from a surgeon who is simultaneously treating individuals and working to improve the system within which that treatment is delivered, a combination of clinical and strategic commitment that speaks well of his dedication to the field.

Where Excellence in Lung Cancer Care Meets Genuine Expertise

The United Kingdom is home to some of the world's most accomplished lung cancer specialists, and the ten consultants profiled here represent the very best that British thoracic oncology has to offer. From the precision oncology delivered through molecular profiling and advanced radiotherapy techniques to the technical artistry of single-incision keyhole surgery and laser-assisted resection, each of these clinicians is advancing the boundaries of what is possible for patients facing one of medicine's most demanding diagnoses. Whether you are seeking a second opinion, exploring private treatment options, or simply wishing to better understand the landscape of specialist care available in the UK, knowing who the leading voices in this field are is the first and most important step toward informed, confident decision-making.